Michael Kinch, PhD
News — STONY BROOK, NY—June 3, 2024— Stony Brook University announced today that Michael Kinch, PhD, has been appointed as the inaugural chief innovation officer (CINO) for the university. Kinch brings extraordinary experience at the highest levels of industry and academia, including roles at Yale and Washington University—two institutions known for their cultures of innovation and demonstrated success translating knowledge into marketable solutions. He will report to the new incoming vice president for research, Kevin Gardner, beginning August 1, 2024 and will be a member of the president’s university council. He will also hold a faculty position in the university’s Department of Pharmacology.
As CINO, Kinch will lead the Office of Economic Development and provide direction and oversight of campus-wide initiatives related to accelerating innovation and economic development, including incubation and technology transfer. His efforts will focus on technology-based entrepreneurship, venture capital, and other sources of startup investment, as well as the research commercialization and economic development programs from faculty and student research and initiatives. In addition, Kinch and his staff will collaborate with departments and colleges/schools across campus to amplify the university's service to advance Stony Brook's economic impact on the region and develop partnerships with external entities that benefit the university and help advance economic development interests of these external entities.
“As a leader who brings people together and who knows that research, scholarship and discovery are a universal language, Michael is an excellent leader to help the university realize its boldest ambitions to make a profound, positive impact on society for generations to come,” said Stony Brook University President Maurie McInnis.
Kinch has worked extensively in higher education including in his most recent role as the executive dean of sciences at Long Island University where he creates and deploys innovative approaches to improve biomedical translation and entrepreneurship. He founded and directed the Center for Research Innovation in Biotechnology, which analyzes the sources of biomedical innovation.
Previous to that position, Kinch served as associate vice chancellor, founder of the Centers for Research Innovation in Biotechnology and Drug Discovery and professor of Biochemistry and Molecular Biophysics at Washington University in St. Louis. There he helped lead entrepreneurship activities and founded the Centers for Research Innovation in Biotechnology (CRIB) and Drug Discovery (CDD), which analyzes innovation in the science and business of medicines. At Yale University, he founded and led the Yale Center for Molecular Discovery. He has been a lecturer at the Krieger Program in Biotechnology at John Hopkins University; associate professor at the Indiana University School of Medicine, West Lafayette Campus at Purdue University; and served as a postdoctoral fellow at the University of North Carolina at Chapel Hill.
Kinch has worked in the private sector overseeing Research and Development as Vice President for Research and Development/Chief Scientific Officer at Functional Genetics, Inc. and Head of Cancer Biology & Translational Sciences at Medimmune, Inc. He is also the author of six books, has published extensively in peer-reviewed publications and participated in national media appearances and interviews about his research.
Kinch earned his PhD in Immunology from Duke University Medical Center and his BS in Molecular Genetics.
“I am excited by the incredible potential for innovative commercial development on Long Island in general and Stony Brook University in particular,” said Kinch. “The university has incredible expertise in key aspects of science and technology that are needed to address looming challenges, including but not limited to affordable and sustainable energy to biomedical applications."
Photo credit: Washington University in St. Louis
# # #
About Stony Brook University
Stony Brook University — New York’s flagship university and No. 1 public university — is going far beyond the expectations of today’s public universities. It is part of the State University of New York (SUNY) system. With nearly 26,000 students, more than 2,900 faculty members, more than 220,000 alumni, a premier academic healthcare system and 18 NCAA Division I athletic programs, Stony Brook is a research-intensive distinguished center of innovation dedicated to addressing the world’s biggest challenges. The university embraces its mission to provide comprehensive undergraduate, graduate and professional education of the highest quality, and is ranked as the #58 overall university and #26 among public universities in the nation by U.S. Â鶹´«Ã½ & World Report’s Best Colleges listing. Fostering a commitment to academic research and intellectual endeavors, Stony Brook’s membership in the Association of American Universities (AAU) places it among the top 71 research institutions in North America. The university’s distinguished faculty have earned esteemed awards such as the Nobel Prize, Pulitzer Prize, Indianapolis Prize for animal conservation, Abel Prize and the Breakthrough Prize in Mathematics. Stony Brook has the responsibility of co-managing Brookhaven National Laboratory for the U.S. Department of Energy — one of only eight universities with a role in running a national laboratory. In 2023, Stony Brook was named the anchor institution for on Governors Island in New York City. Providing economic growth for neighboring communities and the wider geographic region, the university totals an impressive $7.23 billion in increased economic output on Long Island. Follow us on Facebook and X.
RSS